As of 2025-04-18, the Relative Valuation of Applied Therapeutics Inc (APLT) is (30.44) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.30 USD, the upside of Applied Therapeutics Inc based on Relative Valuation is -10121.3%.
The range of the Relative Valuation is (22.36) - (46.44) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 9.0x - 23.0x | 13.6x |
| Forward P/E multiples | 9.7x - 20.1x | 12.7x |
| Fair Price | (22.36) - (46.44) | (30.44) |
| Upside | -7461.6% - -15387.2% | -10121.3% |
| Date | P/E |
| 2025-04-03 | -0.18 |
| 2025-04-02 | -0.19 |
| 2025-04-01 | -0.20 |
| 2025-03-31 | -0.21 |
| 2025-03-28 | -0.22 |
| 2025-03-27 | -0.23 |
| 2025-03-26 | -0.23 |
| 2025-03-25 | -0.24 |
| 2025-03-24 | -0.24 |
| 2025-03-21 | -0.25 |
| 2025-03-20 | -0.22 |
| 2025-03-19 | -0.22 |
| 2025-03-18 | -0.22 |
| 2025-03-17 | -0.24 |
| 2025-03-14 | -0.22 |
| 2025-03-13 | -0.22 |
| 2025-03-12 | -0.23 |
| 2025-03-11 | -0.23 |
| 2025-03-10 | -0.22 |
| 2025-03-07 | -0.25 |
| 2025-03-06 | -0.22 |
| 2025-03-05 | -0.22 |
| 2025-03-04 | -0.21 |
| 2025-03-03 | -0.20 |
| 2025-02-28 | -0.22 |
| 2025-02-27 | -0.22 |
| 2025-02-26 | -0.23 |
| 2025-02-25 | -0.23 |
| 2025-02-24 | -0.23 |
| 2025-02-21 | -0.23 |
| 2025-02-20 | -0.24 |
| 2025-02-19 | -0.25 |
| 2025-02-18 | -0.25 |
| 2025-02-14 | -0.28 |
| 2025-02-13 | -0.26 |
| 2025-02-12 | -0.23 |
| 2025-02-11 | -0.25 |
| 2025-02-10 | -0.26 |
| 2025-02-07 | -0.26 |
| 2025-02-06 | -0.26 |
| 2025-02-05 | -0.26 |
| 2025-02-04 | -0.24 |
| 2025-02-03 | -0.24 |
| 2025-01-31 | -0.25 |
| 2025-01-30 | -0.26 |
| 2025-01-29 | -0.24 |
| 2025-01-28 | -0.25 |
| 2025-01-27 | -0.26 |
| 2025-01-24 | -0.28 |
| 2025-01-23 | -0.26 |